Ottawa Hospital leads Canadian clinical trial on stem cell therapy in MS patients

People with Multiple Sclerosis are holding out great hope tonight over clinical trials that will begin right here in Ottawa. It’s part of an international study into special stem cells that have the ability to repair damage.  

There has been much talk before about stem cells and their therapeutic potential.  This research goes beyond that, looking at the possibility that these particular mesenchymal stem cells might be able to fix nerves ravaged by MS.

For people like 60-year-old Margo Murchison, it is a ray of hope in a bleak future living with her disease that has now become chronic. 

‘I’d like to live a life like everybody else,’ says Murchison, ‘be free to do whatever I want and help other people instead of relying on them to help me.’